Dr. Jeffrey R. Jay, M.D. as of March 31, 2012
Portfolio Holdings for Dr. Jeffrey R. Jay, M.D.
Dr. Jeffrey R. Jay, M.D. holds 29 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Keryx Biopharmaceuticals | 10.4 | $10M | 2.1M | 4.98 | |
| OncoGenex Pharmaceuticals | 9.8 | $9.8M | 734k | 13.29 | |
| Oncothyreon | 8.6 | $8.5M | 2.0M | 4.36 | |
| Santarus | 7.5 | $7.4M | 1.3M | 5.85 | |
| INC Ventrus Biosciences | 6.2 | $6.1M | 613k | 9.97 | |
| China Kanghui Holdings | 6.0 | $5.9M | 313k | 19.01 | |
| Insulet Corporation (PODD) | 4.8 | $4.8M | 250k | 19.14 | |
| Rigel Pharmaceuticals | 4.8 | $4.8M | 592k | 8.05 | |
| Abiomed | 4.7 | $4.7M | 212k | 22.19 | |
| Array BioPharma | 4.2 | $4.1M | 1.2M | 3.41 | |
| Vanda Pharmaceuticals (VNDA) | 3.8 | $3.7M | 780k | 4.79 | |
| Pozen | 3.5 | $3.5M | 575k | 6.00 | |
| Pain Therapeutics | 3.1 | $3.1M | 850k | 3.62 | |
| Gen-Probe Incorporated | 3.0 | $3.0M | 45k | 66.40 | |
| NPS Pharmaceuticals | 2.5 | $2.5M | 2.1M | 1.20 | |
| Palatin Technologies | 2.4 | $2.4M | 3.3M | 0.73 | |
| Amarin Corporation (AMRN) | 2.3 | $2.3M | 204k | 11.32 | |
| Biodel | 2.2 | $2.2M | 3.7M | 0.59 | |
| Merit Medical Systems (MMSI) | 1.7 | $1.7M | 135k | 12.42 | |
| Spectranetics Corporation | 1.6 | $1.6M | 150k | 10.40 | |
| Hansen Medical | 1.5 | $1.5M | 500k | 3.00 | |
| Cardica | 1.5 | $1.5M | 695k | 2.14 | |
| Discovery Laboratories | 1.5 | $1.5M | 550k | 2.68 | |
| Trius Therapeutics | 1.0 | $963k | 180k | 5.35 | |
| Natus Medical | 0.6 | $597k | 50k | 11.94 | |
| Tengion (TNGN) | 0.5 | $505k | 902k | 0.56 | |
| RTI Biologics | 0.2 | $241k | 65k | 3.71 | |
| EpiCept Corporation (EPCT) | 0.0 | $35k | 166k | 0.21 | |
| AMAG Pharmaceuticals | 0.0 | $2.0k | 150.00 | 13.33 |
